Skip to main content
. 2017 Aug 19;19(3):361–374. doi: 10.22074/cellj.2017.4497

Fig.2.

Fig.2

Immunotyping of Wharton’s jelly stem cells (WJSCs). Flow cytometry analysis of WJSCs populations showed positive marker for A. CD44 (98.60%), B. CD105 (91.40 %), C. CD90 (98.30 %), D. CD73 (95.90%) and negative marker for E. CD45 (4.75 %), and F. CD34 (2.74%). Results showed that more than 95% of WJSCs are positive for mesenchymal stem cell markers and negative for hematopoietic stem cells markers.